Kai M. Beeh

Biebricher Allee 34
Wiesbaden, HE 65187, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Impact of a Digital Inhalation Coach on Inhalation Errors and Asthma Control.

Impact of a Digital Inhalation Coach on Inhalation Errors and Asthma Control.

Journal: Journal of aerosol medicine and pulmonary drug delivery

Published: December 23, 2025

Home-Based FeNO Monitoring with the Vivatmo me Device Reveals Type 2 Inflammatory Patterns of Patients with Asthma at Different Treatment Steps: The FeNO@Home Study.

Home-Based FeNO Monitoring with the Vivatmo me Device Reveals Type 2 Inflammatory Patterns of Patients with Asthma at Different Treatment Steps: The FeNO@Home Study.

Journal: Pulmonary therapy

Published: October 24, 2025

Comment on 'comparative validation of handheld fractional exhaled nitric oxide measurements'.

Comment on 'comparative validation of handheld fractional exhaled nitric oxide measurements'.

Journal: Expert review of medical devices

Published: August 18, 2025

Clinically Important Improvements and Disease Stability with Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy in the ELLITHE Trial: A Post Hoc Responder Analysis.

Clinically Important Improvements and Disease Stability with Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy in the ELLITHE Trial: A Post Hoc Responder Analysis.

Journal: Pulmonary therapy

Published: May 19, 2025

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial.

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial.

Journal: International journal of chronic obstructive pulmonary disease

Published: April 12, 2022

The environmental impact of inhaled therapy: making informed treatment choices.

The environmental impact of inhaled therapy: making informed treatment choices.

Journal: The European respiratory journal

Published: July 28, 2021

Pulmonary Therapy Podcast-COVID-19: Research and Real-World Experiences from the Editorial Board.

Pulmonary Therapy Podcast-COVID-19: Research and Real-World Experiences from the Editorial Board.

Journal: Pulmonary therapy

Published: April 13, 2021

Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes.

Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes.

Journal: Pragmatic and observational research

Published: January 21, 2021

The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy

The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy

Journal: Terapevticheskii arkhiv

Published: April 16, 2020

Pulmonary Therapy 2020 Update and Podcast: Meet the Journal's Editors-in-Chief.

Pulmonary Therapy 2020 Update and Podcast: Meet the Journal's Editors-in-Chief.

Journal: Pulmonary therapy

Published: March 06, 2020

COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition.

COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition.

Journal: The European respiratory journal

Published: February 04, 2020

Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.

Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.

Journal: Respiratory research

Published: October 17, 2019

Showing 1-12 of 46

Last Updated: 09/26/2026